News Releases – 2004 ArchiveDISCLAIMER FOR ARCHIVES
The information in AstraZeneca Canada’s News Releases Archive was factually accurate on the date of publication. This information remains on our website for historical purposes only. We assume no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after the applicable release dates.
| Dec 17, 2004 |
Gefitinib (Iressa™) Lung Cancer ISEL Trial Shows No Overall Survival Advantage in a Highly Refractory Population |
| Dec 8, 2004 |
The Lancet: New Standard of Care for Early Breast Cancer Patients |
| Sep 30, 2004 |
First Ever Global Breast Cancer Awareness Campaign Unites Independent Charities From Around the World |
| Jul 14, 2004 |
Health Canada Approval Paves Way for New Era in Breast Cancer Treatment |
| Jun 15, 2004 |
Two New Vice Presidents for AstraZeneca Canada Inc. |
| May 31, 2004 |
NSAIDs and Gastroprotection: Results of Clinical Studies Provide Insights for the Management of Side-effects in NSAID and COX-2 Users |
| May 31, 2004 |
What’s Keeping Canadians Up At Night? |
| May 6, 2004 |
Atacand® Product Monograph Change Acknowledges Greater Hypertension Control |
| Apr 30, 2004 |
Endowed Chair for Asthma Research at U of A Made Possible by AstraZeneca Canada |
| Mar 22, 2004 |
Symbicort® Single Inhaler Therapy (Symbicort® SiT) Demonstrates Superior Asthma Control Using Only One Inhaler |
| Mar 3, 2004 |
International Specialist Recruited to Canada to Hold Newly Established Chair in Gastrointestinal Research at McMaster University |
| Mar 1, 2004 |
EXPO Study Confirms Nexium® Offers Superior Healing of Reflux Esophagitis and Resolution of Heartburn Compared to Pantoprazole |
| Mar 1, 2004 |
The Heartburn War: Image and Research At Odds |
| Jan 9, 2004 |
Universal Access to the Best Available Medications Should Be a National Priority, New Survey Shows |
|
